CD68-Positive Cells in Hepatic Angiomyolipoma

Hitoshi Tochio1, Eriko Tamaki, Yukihiro Imai

  • 1Department of Clinical Laboratory Medicine, Kobe City Medical Center General Hospital, Kobe, , Japan.

Oncology
|December 29, 2016
PubMed

Insights

Sonazoid contrast agent uptake in hepatic angiomyolipoma is linked to macrophage density. Immunohistochemical analysis confirmed CD68-positive cells correlate with Sonazoid enhancement in ultrasonography.

Area of Science:

  • Hepatobiliary imaging
  • Tumor pathology
  • Radiology

Background:

  • Hepatic angiomyolipoma is a benign liver tumor.
  • Sonazoid is a contrast agent used in ultrasonography.
  • Understanding contrast agent behavior in tumors is crucial for diagnosis.

Purpose of the Study:

  • To investigate the relationship between Sonazoid uptake and macrophage presence in hepatic angiomyolipoma.
  • To determine if macrophage density correlates with Sonazoid enhancement in the postvascular phase.

Main Methods:

  • Analysis of four resected hepatic angiomyolipoma specimens.
  • Sonazoid-enhanced ultrasonography to assess contrast uptake.
  • Immunohistochemical staining for CD68 to identify macrophages.

Main Results:

  • Sonazoid uptake was observed in the postvascular phase in all cases.
  • CD68-positive cells (macrophages) were present in all tumors.
  • Tumor macrophage density correlated with the degree of Sonazoid uptake.

Conclusions:

  • Macrophage density is a key factor in Sonazoid uptake in hepatic angiomyolipoma.
  • Sonazoid-enhanced ultrasonography may provide insights into tumor composition.
  • Further research can explore the diagnostic potential of this finding.

Related Concept Videos